Amgen stock trades steady as biosimilar growth offsets mixed Q1 2026 trends

Amgen stock trades steady as biosimilar growth offsets mixed Q1 2026 trends  Ad-hoc-news.de

Summary aggregated from Ad-hoc-news.de's public RSS feed. The full reporting belongs to Ad-hoc-news.de — please read it on their site.